{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:08:08Z","timestamp":1792692488830,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["71722"],"award-info":[{"award-number":["71722"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111230","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T19:38:23Z","timestamp":1700163503000},"page":"111230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro"],"prefix":"10.1016","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4596-2508","authenticated-orcid":false,"given":"Shiva","family":"Alipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohid","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad Ahmadian","family":"Heris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Baghbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Sohrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8642-6795","authenticated-orcid":false,"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.111230_b0005","first-page":"1","article-title":"Pathogenesis of autoimmune disease","author":"Pisetsky","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111230_b0010","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/jpm13030422","article-title":"Type 1 diabetes mellitus and autoimmune diseases: a critical review of the association and the application of personalized medicine","volume":"13","author":"Popoviciu","year":"2023","journal-title":"J. Personal. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.111230_b0015","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1530\/EC-17-0347","article-title":"On type 1 diabetes mellitus pathogenesis","volume":"7","author":"Paschou","year":"2018","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.intimp.2023.111230_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.931316","article-title":"CTLA-4 silencing in dendritic cells loaded with colorectal cancer cell lysate improves autologous T cell responses in vitro","volume":"13","author":"Ghorbaninezhad","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.111230_b0025","doi-asserted-by":"crossref","unstructured":"A. Gardner, \u00c1. de Mingo Pulido, B. Ruffell, Dendritic cells and their role in immunotherapy, Front. Immunol. 11 (2020) 924, 2020.","DOI":"10.3389\/fimmu.2020.00924"},{"issue":"1","key":"10.1016\/j.intimp.2023.111230_b0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic dendritic cells in autoimmunity and inflammatory diseases","volume":"42","author":"Morante-Palacios","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.intimp.2023.111230_b0035","first-page":"ltad012","article-title":"Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: The route of administration, Immunotherapy","author":"Jos\u00e9 Mansilla","year":"2023","journal-title":"Advances"},{"issue":"9","key":"10.1016\/j.intimp.2023.111230_b0040","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2023.111230_b0045","doi-asserted-by":"crossref","first-page":"1054968","DOI":"10.3389\/fimmu.2022.1054968","article-title":"Tolerogenic dendritic cells pulsed with islet antigen induce long-term reduction in T-cell autoreactivity in type 1 diabetes patients","volume":"13","author":"Nikolic","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2023.111230_b0050","first-page":"1003","article-title":"Inflammasome in dendritic cells immunobiology: implications to diseases and therapeutic strategies","volume":"18","author":"Teresa Cruz","year":"2017","journal-title":"Curr. Drug Targets"},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0055","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3390\/ijms22020872","article-title":"Structure, activation and regulation of NLRP3 and AIM2 inflammasomes","volume":"22","author":"Sharma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0060","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4049\/jimmunol.0901363","article-title":"Cutting edge: NF-\u03baB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression","volume":"183","author":"Bauernfeind","year":"2009","journal-title":"J. Immunol."},{"issue":"7081","key":"10.1016\/j.intimp.2023.111230_b0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and ATP","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.4049\/jimmunol.1500530","article-title":"Bacterial RNA: an underestimated stimulus for innate immune responses","volume":"195","author":"Eigenbrod","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.111230_b0075","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3389\/fimmu.2020.01595","article-title":"The NLRP3 inflammasome and its role in T1DM","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0080","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4049\/jimmunol.0904145","article-title":"NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses","volume":"185","author":"Gris","year":"2010","journal-title":"J. Immunol."},{"issue":"13","key":"10.1016\/j.intimp.2023.111230_b0085","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.111230_b0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.intimp.2019.05.006","article-title":"NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy","volume":"73","author":"Parsamanesh","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.111230_b0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fendo.2020.00119","article-title":"Advances in knowledge of candidate genes acting at the beta-cell level in the pathogenesis of T1DM","volume":"11","author":"Pang","year":"2020","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111230_b0100","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.drudis.2021.02.018","article-title":"Specific NLRP3 inflammasome inhibitors: promising therapeutic agents for inflammatory diseases","volume":"26","author":"Vong","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.intimp.2023.111230_b0105","doi-asserted-by":"crossref","first-page":"772","DOI":"10.2337\/db20-0357","article-title":"Specific NLRP3 inhibition protects against diabetes-associated atherosclerosis","volume":"70","author":"Sharma","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2023.111230_b0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molimm.2019.10.027","article-title":"MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome","volume":"117","author":"Chen","year":"2020","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.111230_b0115","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1172\/JCI25495","article-title":"ATP-sensitive potassium channelopathies: focus on insulin secretion","volume":"115","author":"Ashcroft","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2023.111230_b0120","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3578702","article-title":"A protective role of glibenclamide in inflammation-associated injury","volume":"2017","author":"Zhang","year":"2017","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2023.111230_b0125","article-title":"Targeting the NOD-like receptor Pyrin domain containing 3 inflammasome to improve healing of diabetic wounds","author":"Cavalcante-Silva","year":"2022","journal-title":"Adv. Wound Care"},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0130","doi-asserted-by":"crossref","first-page":"432","DOI":"10.7150\/ijms.47197","article-title":"TLR2 and the NLRP3 inflammasome mediate IL-1\u03b2 production in Prevotella nigrescens-infected dendritic cells","volume":"18","author":"Jang","year":"2021","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.111230_b0135","doi-asserted-by":"crossref","first-page":"e0170125","DOI":"10.1371\/journal.pone.0170125","article-title":"Differences in inflammatory response induced by two representatives of clades of the pandemic ST258 Klebsiella pneumoniae clonal lineage producing KPC-type carbapenemases","volume":"12","author":"Castronovo","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0140","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.atherosclerosis.2012.11.016","article-title":"Up-regulated ATP-sensitive potassium channels play a role in increased inflammation and plaque vulnerability in macrophages","volume":"226","author":"Ling","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.intimp.2023.111230_b0145","doi-asserted-by":"crossref","first-page":"2300142","DOI":"10.1002\/adbi.202300142","article-title":"Regulation of Dendritic Cell Functions by Vitamins as Promising Therapeutic Strategy for Immune System Disorders","author":"Ghahramanipour","year":"2023","journal-title":"Advanced Biology"},{"issue":"5","key":"10.1016\/j.intimp.2023.111230_b0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4239\/wjd.v12.i5.603","article-title":"Current advances in using tolerogenic dendritic cells as a therapeutic alternative in the treatment of type 1 diabetes","volume":"12","author":"de Jes\u00fas R\u00edos-R\u00edos","year":"2021","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.intimp.2023.111230_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.07.011","article-title":"Regulatory dendritic cells in autoimmunity: a comprehensive review","volume":"63","author":"Liu","year":"2015","journal-title":"J. Autoimmun."},{"issue":"775","key":"10.1016\/j.intimp.2023.111230_b0160","doi-asserted-by":"crossref","first-page":"eabn9909","DOI":"10.1126\/scisignal.abn9909","article-title":"The kinetics of signaling through the common FcR\u03b3 chain determine cytokine profiles in dendritic cells","volume":"16","author":"Watanabe","year":"2023","journal-title":"Sci. Signal."},{"issue":"8","key":"10.1016\/j.intimp.2023.111230_b0165","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1096\/fj.201601349R","article-title":"Inhibition of inflammasome activation improves lung acute injury induced by carrageenan in a mouse model of pleurisy","volume":"31","author":"Fusco","year":"2017","journal-title":"FASEB J."},{"issue":"17","key":"10.1016\/j.intimp.2023.111230_b0170","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.3390\/ijms21176266","article-title":"Immunomodulation and generation of tolerogenic dendritic cells by probiotic bacteria in patients with inflammatory bowel disease","volume":"21","author":"Ghavami","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0175","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.intimp.2014.12.009","article-title":"Asiatic acid ameliorates dextran sulfate sodium-induced murine experimental colitis via suppressing mitochondria-mediated NLRP3 inflammasome activation","volume":"24","author":"Guo","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111230_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2023.111230_b0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nrendo.2009.271","article-title":"Blockade of interleukin 1 in type 1 diabetes mellitus","volume":"6","author":"Mandrup-Poulsen","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111230_b0190","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/cells8121595","article-title":"NLRP3 inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus","volume":"8","author":"Ferreira","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.intimp.2023.111230_b0195","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1210\/jc.2007-0979","article-title":"Gene expression in peripheral blood mononuclear cells from children with diabetes","volume":"92","author":"Kaizer","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.intimp.2023.111230_b0200","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41419-018-0764-x","article-title":"NLRP3 inflammasome is expressed and regulated in human islets","volume":"9","author":"Lebreton","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.111230_b0205","doi-asserted-by":"crossref","unstructured":"C. Hu, H. Ding, Y. Li, J.A. Pearson, X. Zhang, R.A. Flavell, F.S. Wong, L. Wen, NLRP3 deficiency protects from type 1 diabetes through the regulation of chemotaxis into the pancreatic islets, Proceedings of the National Academy of Sciences 112(36) (2015) 11318-11323.","DOI":"10.1073\/pnas.1513509112"},{"issue":"1","key":"10.1016\/j.intimp.2023.111230_b0210","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4049\/jimmunol.1701604","article-title":"Effective combination adjuvants engage both TLR and inflammasome pathways to promote potent adaptive immune responses","volume":"201","author":"Seydoux","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2023.111230_b0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2021.06.014","article-title":"NLRP3-activated bone marrow dendritic cells play antileukemic roles via IL-1\u03b2\/Th1\/IFN-\u03b3 in acute myeloid leukemia","volume":"520","author":"Liu","year":"2021","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.intimp.2023.111230_b0220","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1\u03b2\u2013dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.intimp.2023.111230_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108381","article-title":"Inflammasomes within hyperactive murine dendritic cells stimulate long-lived T cell-mediated anti-tumor immunity","volume":"33","author":"Zhivaki","year":"2020","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.immuni.2015.07.018","article-title":"The PYRIN domain-only protein POP1 inhibits inflammasome assembly and ameliorates inflammatory disease","volume":"43","author":"de Almeida","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2023.111230_b0235","first-page":"1","article-title":"Advanced Delivery Strategies for Immunotherapy in Type I Diabetes Mellitus","author":"Huang","year":"2023","journal-title":"BioDrugs"},{"issue":"9","key":"10.1016\/j.intimp.2023.111230_b0240","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.humimm.2012.06.008","article-title":"Central and overlapping role of Cathepsin B and inflammasome adaptor ASC in antigen presenting function of human dendritic cells","volume":"73","author":"Guo","year":"2012","journal-title":"Hum. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111230_b0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jinf.2018.03.004","article-title":"NLRP3 inflammasome is involved in the recognition of Paracoccidioides brasiliensis by human dendritic cells and in the induction of Th17 cells","volume":"77","author":"de Castro","year":"2018","journal-title":"J. Infect."},{"issue":"12","key":"10.1016\/j.intimp.2023.111230_b0250","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.7150\/thno.33178","article-title":"Knockdown of NEAT1 induces tolerogenic phenotype in dendritic cells by inhibiting activation of NLRP3 inflammasome","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2023.111230_b0255","first-page":"1","article-title":"Insulin-Attenuated Inflammatory Response of Dendritic Cells in Diabetes by Regulating RAGE-PKC\u03b21-IRS1-NF-\u03baB Signal Pathway: A Study on the Anti-Inflammatory Mechanism of Insulin in Diabetes","volume":"2020","author":"Zhao","year":"2020","journal-title":"Journal of Diabetes Research"},{"issue":"15","key":"10.1016\/j.intimp.2023.111230_b0260","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.3390\/ijms22158274","article-title":"Probiotic-induced tolerogenic dendritic cells: a novel therapy for inflammatory bowel disease?","volume":"22","author":"Baradaran Ghavami","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2023.111230_b0265","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.clim.2014.06.009","article-title":"Tolerogenic dendritic cells induce antigen-specific hyporesponsiveness in insulin-and glutamic acid decarboxylase 65-autoreactive T lymphocytes from type 1 diabetic patients","volume":"154","author":"Segovia-Gamboa","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2023.111230_b0270","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10875-010-9430-5","article-title":"IL-10\/TGF-\u03b2-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector\/memory T cells from type 1 diabetic individuals","volume":"30","author":"Torres-Aguilar","year":"2010","journal-title":"J. Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923015576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:13:01Z","timestamp":1761588781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923015576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":54,"alternative-id":["S1567576923015576"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111230","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111230","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111230"}}